Stock Track | The Chemours Company Reports Fourth Quarter and Full Year 2024 Results

Stock Track

Feb 19, 2025

- Chemours reported Q4 2024 net sales of $1.36 billion, down 1% year-over-year, driven by a 3% decrease in pricing partially offset by a 2% increase in volume.

- Q4 adjusted EBITDA was $179 million, up 2% year-over-year, driven by cost savings from the TT Transformation Plan, favorable inventory adjustments and higher volumes in TSS, partially offset by lower pricing.

- For full year 2024, net sales were $5.78 billion, down 5% year-over-year due to lower pricing and portfolio changes, while adjusted EBITDA was $786 million, down 22% due to lower pricing, unfavorable currency impacts and higher costs.

- The company provided 2025 adjusted EBITDA guidance of $825-$975 million, expecting growth in Opteon Refrigerants and cost savings from the Pathway to Thrive strategy.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1180416870"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1180416870\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1180416870?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-19 03:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180416870","market":"hk","top_or_hot":-1,"title":"Stock Track | The Chemours Company Reports Fourth Quarter and Full Year 2024 Results","media":"Stock Track","content":"<p>- Chemours reported Q4 2024 net sales of $1.36 billion, down 1% year-over-year, driven by a 3% decrease in pricing partially offset by a 2% increase in volume.</p>\n<p>- Q4 adjusted EBITDA was $179 million, up 2% year-over-year, driven by cost savings from the TT Transformation Plan, favorable inventory adjustments and higher volumes in TSS, partially offset by lower pricing.</p>\n<p>- For full year 2024, net sales were $5.78 billion, down 5% year-over-year due to lower pricing and portfolio changes, while adjusted EBITDA was $786 million, down 22% due to lower pricing, unfavorable currency impacts and higher costs.</p>\n<p>- The company provided 2025 adjusted EBITDA guidance of $825-$975 million, expecting growth in Opteon Refrigerants and cost savings from the Pathway to Thrive strategy.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | The Chemours Company Reports Fourth Quarter and Full Year 2024 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | The Chemours Company Reports Fourth Quarter and Full Year 2024 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-19 03:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>- Chemours reported Q4 2024 net sales of $1.36 billion, down 1% year-over-year, driven by a 3% decrease in pricing partially offset by a 2% increase in volume.</p>\n<p>- Q4 adjusted EBITDA was $179 million, up 2% year-over-year, driven by cost savings from the TT Transformation Plan, favorable inventory adjustments and higher volumes in TSS, partially offset by lower pricing.</p>\n<p>- For full year 2024, net sales were $5.78 billion, down 5% year-over-year due to lower pricing and portfolio changes, while adjusted EBITDA was $786 million, down 22% due to lower pricing, unfavorable currency impacts and higher costs.</p>\n<p>- The company provided 2025 adjusted EBITDA guidance of $825-$975 million, expecting growth in Opteon Refrigerants and cost savings from the Pathway to Thrive strategy.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CC","symbol_name":"Chemours Company","start_time":0,"source_url":"","article_id":"1180416870","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180416870","pubTimestamp":1739905525,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"- Chemours reported Q4 2024 net sales of $1.36 billion, down 1% year-over-year, driven by a 3% decrease in pricing partially offset by a 2% increase in volume.- Q4 adjusted EBITDA was $179 million, up 2% year-over-year, driven by cost savings from the TT Transformation Plan, favorable inventory adjustments and higher volumes in TSS, partially offset by lower pricing.- For full year 2024, net sales were $5.78 billion, down 5% year-over-year due to lower pricing and portfolio changes, while adjust","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CC":"Chemours Company"},"translate_title":"股票追踪科慕公司报告2024年第四季度和全年业绩","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CC":1},"content_text":"- Chemours reported Q4 2024 net sales of $1.36 billion, down 1% year-over-year, driven by a 3% decrease in pricing partially offset by a 2% increase in volume.\n- Q4 adjusted EBITDA was $179 million, up 2% year-over-year, driven by cost savings from the TT Transformation Plan, favorable inventory adjustments and higher volumes in TSS, partially offset by lower pricing.\n- For full year 2024, net sales were $5.78 billion, down 5% year-over-year due to lower pricing and portfolio changes, while adjusted EBITDA was $786 million, down 22% due to lower pricing, unfavorable currency impacts and higher costs.\n- The company provided 2025 adjusted EBITDA guidance of $825-$975 million, expecting growth in Opteon Refrigerants and cost savings from the Pathway to Thrive strategy.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}